News Check all IrsiCaixa scientific news in just one click. Breadcrumb Home News 11/01/2016 Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine 01/11/2015 IrsiCaixa and IDIBAPS participate in a 23 million euro project to develop HIV vaccine 20/10/2015 Roger Paredes, new member of the WHO HIV Drug Resistance Steering Group 06/10/2015 Bonaventura Clotet opens the 5th edition of the Master in AIDS Pathogenesis and Treatment 27/07/2015 A study notes the need to start HIV treatment on perinatally infected babies within the first 12 weeks of life 01/07/2015 Lack of microbial diversity is a risk factor for chronic diseases 29/06/2015 IrsiCaixa: four years helping to improve education in health sciences with the Tandem project 16/06/2015 A study highlights the need for alternative drugs in Africa for patients who develop resistance to HIV drugs 04/06/2015 Five molecules for future international studies on CFS have been identified Pagination First Previous … Page 16 Page 17 Page 18 Page 19 20 Page 21 Page 22 Page 23 Page 24 … Next Last
11/01/2016 Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine
27/07/2015 A study notes the need to start HIV treatment on perinatally infected babies within the first 12 weeks of life
29/06/2015 IrsiCaixa: four years helping to improve education in health sciences with the Tandem project
16/06/2015 A study highlights the need for alternative drugs in Africa for patients who develop resistance to HIV drugs